Atrion Corp. (NASDAQ:ATRI) Chairman Emile A. Battat sold 1,102 shares of the stock in a transaction on Thursday, November 10th. The stock was sold at an average price of $443.01, for a total value of $488,197.02. Following the sale, the chairman now directly owns 142,968 shares in the company, valued at $63,336,253.68. The transaction was disclosed in a filing with the SEC, which is accessible through this link.

Shares of Atrion Corp. (NASDAQ:ATRI) opened at 463.80 on Tuesday. The firm has a market capitalization of $845.97 million, a price-to-earnings ratio of 30.65 and a beta of 0.81. The stock’s 50 day moving average price is $432.40 and its 200 day moving average price is $431.37. Atrion Corp. has a 12-month low of $350.00 and a 12-month high of $490.45.

Insider Buying and Selling by Quarter for Atrion Corp. (NASDAQ:ATRI)

The business also recently announced a quarterly dividend, which will be paid on Thursday, December 15th. Investors of record on Thursday, December 1st will be given a dividend of $1.05 per share. The ex-dividend date of this dividend is Tuesday, November 29th. This represents a $4.20 annualized dividend and a dividend yield of 0.91%. Atrion Corp.’s payout ratio is 27.72%.

Atrion Corp. Company Profile

Atrion Corporation (Atrion) is engaged in developing and manufacturing products, primarily for medical applications. The Company’s medical products range from fluid delivery devices to ophthalmic and cardiovascular products. Its fluid delivery products include valves that promote infection control and needle safety.

5 Day Chart for NASDAQ:ATRI

Receive News & Stock Ratings for Atrion Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Atrion Corp. and related stocks with our FREE daily email newsletter.